High risk:
bacteremia (use ceftriaxone; HIV testing recommended)
severe prolonged symptoms
hemodialysis
hemoglobinopathy, e.g. sickle cell disease
severe atherosclerotic disease
vascular graft
valvular heart disease
patients > 50 years
High risk:
bacteremia (use ceftriaxone; HIV testing recommended)
severe prolonged symptoms
hemodialysis
hemoglobinopathy, e.g. sickle cell disease
severe atherosclerotic disease
vascular graft
valvular heart disease
patients > 50 years